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DC COVID-19 STATS THROUGH APRIL 26

https://coronavirus.dc.gov/page/coronavirus-data
From the Mayor’s Presentation on DC’s COVID-19 Situational Update of April 24, 2020:

● The Virginia Hospital & Healthcare Association has launched an online dashboard of
currently hospitalized patients with COVID-19, available beds, and other resources.
● The Maryland Emergency Management Agency also maintains a COVID-19 dashboard
based on data released by the Governor’s office and the Maryland Department of Health.
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THEMES OF THE WEEK
● Professional organizations and States are developing strategies for easing social distancing
requirements. Until highly effective new methods of treatment and prevention of COVID-19
are discovered, public health experts recommend a mass investment in testing, contact tracing,
outbreak containment, and careful easing of social distancing based on local realities, in order
to reduce the risk of mortality from repeat waves of the pandemic.
● Epidemiological and clinical experiences from China, Italy, New York and other early-hit
communities are being published to help clinicians diagnose and manage patients.
● Our understanding of pulmonary and vascular pathology in this disease is growing. This
includes considerable concern about coagulation abnormalities seen in COVID-19 patients.
● NIH and other health professional organizations are publishing guidelines and
recommendations for practice based on these experiences and expert opinion. These are sure
to be modified as knowledge accrues.
● Early results of research on the use of various therapeutics are being published. Most are not
peer reviewed and few are controlled, so we must interpret them with great caution.
● Serologic testing is a promising strategy for defining the prevalence of asymptomatic
infections. However, results must be interpreted cautiously given the current limits on the
sensitivity and specificity of the tests, and the absence of knowledge about the level of
protective immunity that may be conferred.

CLINICAL KNOWLEDGE
Diagnostics
Title: CDC updates COVID-19 laboratory testing FAQs
Publisher: US Centers for Disease Control and Prevention
Publication: April 21, 2020
URL: https://www.cdc.gov/coronavirus/2019-ncov/lab/testing-laboratories.html
Key Takeaway:
● CDC updated and expanded its FAQs on COVID-19 laboratory testing and reporting
April 20, 2020. Topics include accessing laboratory testing, data and reporting, serology
testing and ordering supplies.
Title: Developing a National Strategy for Serology (Antibody Testing) in the United States
Publisher: Johns Hopkins Center for Health Security
Publication: April 22, 2020
URL: https://www.centerforhealthsecurity.org/our-work/publications/developing-a-nationalstrategy-for-serology-antibody-testing-in-the-US
Key Takeaway:
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● Serologic testing has the potential to provide valuable information for public health
decision-making when conducted as a complement to molecular testing, and is also in
demand from individuals and employers to determine perceived immunity.
● It is imperative to validate the tests as well as provide information about the uncertainties
of the results. In addition to the potential for false positive and negative results, important
areas of uncertainty that must be addressed through research include how long immunity
lasts after infection, and whether that immune response is protective.

Therapeutics
Title: NIAID Covid-19 Treatment Guidelines
Submitted by: US National Institutes of Health
Publication: April 21, 2020 (continuously updated)
URL: https://covid19treatmentguidelines.nih.gov/
Key Takeaway:
● At present, no drug has been proven to be safe and effective for treating COVID-19.
There continue to be no FDA-approved drugs specifically for COVID-19. These
recommendations will be updated frequently as new trial data emerges.
● There are insufficient clinical data to recommend either for or against use of the
following: hydroxychloroquine or chloroquine, remdesivir, convalescent plasma, IL-6
inhibitors (e.g. sarilumab, tocilizumab), or IL-1 inhibitors (e.g., anakinra).
● The following should be given only as part of a clinical trial, or avoided:
hydroxychloroquine and azithromycin in combination (due to risk of toxicity),
lopinavir/ritonavir or other HIV protease inhibitors, interferons, Janus kinase inhibitors.
● Recommendations for critical care, and concomitant medications, are also provided.
Title: Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Publisher: New England Journal of Medicine
Publication: April 23, 2020
URL: https://www.nejm.org/doi/full/10.1056/NEJMsr2005760
Key Takeaway:
● There are theoretical considerations that ACE inhibitors or ARBs may influence the
infectivity of SARS-CoV-2. However, these drugs have established benefits in protecting
the kidney and myocardium, and their withdrawal may risk clinical decompensation in
high-risk patients. In stable patients with COVID-19 they should be continued.
Title: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for
Prevention, Antithrombotic Therapy, and Follow-up
Publisher: Journal of the American Journal of Cardiology
Publication: April 15, 2020
URL: http://www.onlinejacc.org/content/early/2020/04/15/j.jacc.2020.04.031
Key Takeaway:

10

● Reports suggest unexpectedly common occurrence of venous thromboembolic disease in
patients with severe COVID-19. This review summarizes the current understanding of the
pathogenesis, epidemiology, management, and outcomes of this complication.
● Drug-drug interactions between antiplatelet agents and anticoagulants with
investigational COVID-19 therapies should be considered.

General/Hospitalist
Title: Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients
Hospitalized With COVID-19 in the New York City Area
Publisher: JAMA Network
Publication: April 22, 2020
URL: https://jamanetwork.com/journals/jama/fullarticle/2765184
Key Takeaway:
● Among patients who were discharged or died (n=2,634), 14.2% required ICU care,
12.2% received invasive mechanical ventilation, 3.2% needed renal replacement therapy,
and 21% died.
● Among patients who received mechanical ventilation (n=320), mortality was 76.4% for
ages 18-65 and 97.2% for those aged >65. Among patients who did not receive
mechanical ventilation, mortality was 19.8% and 26.6%, respectively.

Critical Care
Title: Respiratory Support in Novel Coronavirus Disease (COVID-19) Patients
Publisher: American Journal of Tropical Medicine and Hygiene
Publication: April 21, 2020
URL: https://doi.org/10.4269/ajtmh.20-0283
Key Takeaway:
● Supplemental oxygen is the first essential step in the treatment of severe COVID-19
patients with hypoxemia. It can be delivered using a non-rebreathing mask and prone
positioning. This can help extend vent availability in low-resource settings.
● For patients requiring invasive ventilation due to exhaustion or other cause, lung
protective strategies may reduce the currently very high CFR of >50%.
Title: Management of COVID-19 Respiratory Distress
Publisher: JAMA Network
Publication: April 24, 2020
URL: https://jamanetwork.com/journals/jama/fullarticle/2765302
Key Takeaway:
● With the understanding that COVID-19 is not purely a respiratory pathogen but a
systemic disease that injures the vascular endothelium, the management of ARDS in
patients with COVID-19 may need to differ from the usual approach.
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● COVID-19 patients initially tend to retain relatively good compliance despite very poor
oxygenation (“Type L” lung disease). This may progress in some patients, either because
of disease severity, host response, or suboptimal management, to “Type H” disease
characterized by low compliance, higher lung weight, and higher PEEP response.
● Lung-protective ventilation strategies must be adjusted to the stage and type of disease.
● This follows a previous report.

Cardiology
Title: Management of Acute Myocardial Infarction During the COVID-19; A Consensus
Statement from the Society for Cardiovascular Angiography and Interventions (SCAI),
American College of Cardiology (ACC), and the American College of Emergency
Physicians (ACEP)
Publisher: Journal of the American College of Cardiology
Publication: April, 2020
URL: http://www.onlinejacc.org/content/accj/early/2020/04/17/j.jacc.2020.04.039.full.pdf
Key Takeaway:
● During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI
patients at PCI capable hospitals when it can be provided in a timely fashion, with an
expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy
may be entertained at non-PCI capable referral hospitals or in specific situations.
Title: Endothelial cell infection and endotheliitis in COVID-19, Lancet, April 20, 2020
Publisher: The Lancet
Publication: April 20, 2020 (letter)
URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30937-5/fulltext
Key Takeaway:
● Viral inclusions of SARS-CoV-2 can be detected in endothelial cells, suggesting a
mechanism of direct viral injury to the endothelium that may explain some of the clinical
findings observed in severe COVID-19.

OB/Gyn
Title: Outpatient Assessment and Management for Pregnant Women with Suspected or
Confirmed Novel Coronavirus (COVID-19)
Publisher: Society for Maternal-Fetal Medicine
Publication: April 22, 2020
URL: https://www.smfm.org/covidclinical
Key Takeaway:
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● The Society for Maternal-Fetal Medicine (SMFM) and the American College of
Obstetricians and Gynecologists (ACOG) have developed an algorithm for assessment
and management of pregnant women with COVID-19 (available in English and Spanish).
● SMFM and the Society for Obstetric Anesthesia and Perinatology (SOAP) continue to
revise and update their guidance on Labor and Delivery COVID-19 Considerations.
● In their previously released statement, SMFM and ACOG state that while the CDC
currently “does not indicate that pregnancy alone puts people at higher risk for severe
illness resulting from COVID-19 infection,” the evidence underlying this statement is
limited and will be augmented over time by additional data and testing.
Title: Clinical Characteristics of Pregnant Women with COVID-19 in Wuhan China,
NEJM, April 17, 2020
Publisher: New England Journal of Medicine
Publication: April 17, 2020
URL: https://www.nejm.org/doi/full/10.1056/NEJMc2009226
Key Takeaway:
● On this review of pregnant women treated for COVID-19 in December 2019-March 2020
in Wuhan, the risk of severe disease appeared to be similar to that in the general
population. Nine of 118 patients had severe disease and only one required ventilation.

Surgery
Title: Joint Statement: Roadmap for Resuming Elective Surgery after COVID-19
Pandemic
Publisher: American Society of Anesthesiologists
Publication: April 17, 2020
URL: https://www.asahq.org/about-asa/newsroom/news-releases/2020/04/joint-statement-onelective-surgery-after-covid-19-pandemic
Key Takeaway:
● This is a joint statement from the American College of Surgeons, American Society of
Anesthesiologists, Association of periOperative Registered Nurses, and American
Hospital Association regarding when it may be safe to resume elective surgeries.
● Eight key considerations are outlined: timing for reopening of elective surgery, COVID19 testing in the facility, PPE, case prioritization and scheduling, post-COVID-19 issues,
collection and management of data, COVID-related safety and risk mitigation
surrounding the “second wave,” and additional COVID-19-related issues.

Pediatrics
Title: Epidemiological Characteristics of 2,143 Pediatric Patients With 2019 Coronavirus
Disease in China
Publisher: Pediatrics: Official Journal of the American Society of Pediatrics
Publication: March 16, 2020
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URL: https://pediatrics.aappublications.org/content/early/2020/03/16/peds.2020-0702.1
Key Takeaway:
● Children at all ages appeared susceptible to COVID-19, and there was no significant
gender difference. Over 90% had asymptomatic, mild, or moderate disease. The number
of fatalities has been extremely low.
Title: Ventilator Simulator for Pediatrics
Publisher: Open Pediatrics
Publication: April 2020
URL: https://www.openpediatrics.org/assets/simulator/ventilator-simulator
Key Takeaway:
● This is a free simulator for training on ventilator management in pediatric patients.

Emergency Medicine
Title: ACEP COVID-19 Field Guide
Publisher: American Society of Emergency Physicians
Publication: April 20, 2020 (continuously updated)
URL: https://www.acep.org/corona/covid-19-field-guide/publishers-notice/
Key Takeaway:
● This is a continuously updated guide for emergency medicine practitioners, not meant to
be definitive or to establish a single standard of care. The publishers note not all of the
suggestions in the guide are evidence-based.
● It is easily searchable and navigable and provides links and references to resources for
clarification and further information. Sections include home and work safety, triage, EMS,
and patient treatment.

Title: US DHHS/ASPR COVID-19 Clinical Rounds
Publisher: US Department of Health and Human Services (DHHS) Office of the Assistant
Secretary for Preparedness and Response (ASPR)
Publication: April 21, 2020
URL: https://echo.unm.edu/covid-19/sessions/hhs-aspr-clinical-rounds
Key Takeaway:
● A series of webinars and discussions launched by DHHS/ASPR and Project ECHO, on
patient care and operations within Emergency Medicine, EMS, and Critical Care.

HEALTH WORKFORCE
Title: The AMA Medical education COVID-19 resource guide
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Publisher: American Medical Association
Publication: April 2020
URL: https://www.ama-assn.org/delivering-care/public-health/medical-education-covid-19resource-guide
Key Takeaway:
● A compendium of resources on the impact of the COVID-19 crisis on medical trainees,
including guidance on graduations, exams, licensing, and employment.
Title: The ANA COVID-19 Resource Center
Publisher: American Nursing Association
Publication: April 2020
URL: https://www.nursingworld.org/practice-policy/work-environment/health-safety/disasterpreparedness/coronavirus/
Key Takeaway:
● Resources by the American Nursing Association for informing and supporting nurses
during the COVID-19 crisis. Includes resources on clinical care, continuing education,
advocacy, well-being, ethics, and more.

EPIDEMIOLOGY AND PUBLIC HEALTH
Title: Population-Based Estimates of Chronic Conditions Affecting Risk for Complications
from Coronavirus Disease, United States
Publisher: Emerging Infectious Diseases
Publication: April 23, 2020
URL: https://wwwnc.cdc.gov/eid/article/26/8/20-0679_article
Key Takeaway:
● Over 45% of US adults are at increased risk for complications from coronavirus disease
because of cardiovascular disease, diabetes, respiratory disease, hypertension, or other
conditions which predispose to more severe disease. Rates of co-morbidities increase by
age, from 19.8% for persons 18–29 years of age to 80.7% for persons >80 years of age,
and vary by state, race/ethnicity, health insurance status, and employment.

GOVERNMENT/POLICY UPDATES
Title: HHS COVID-19 Frequently Asked Questions For Hospitals, Hospital Laboratory,
and Acute Care Facility Data Reporting
Publisher: US Federal Emergency Management Administration
Publication: April 10, 2020
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URL: https://www.fema.gov/news-release/2020/04/10/coronavirus-covid-19-pandemic-hhsletter-hospital-administrators
Key Takeaway:
● In this document addressing hospital administrators, the US Secretary of DHHS details
the Federal Government's data needs, explains the division of reporting responsibility
between hospitals and states, and gives options for the delivery of this information.
Title: Public Health Principles for a Phased Reopening During COVID-19: Guidance for
Governors
Publisher: The Johns Hopkins Center for Health Security
Publication: April 17, 2020
URL: https://www.centerforhealthsecurity.org/our-work/publications/public-health-principlesfor-a-phased-reopening-during-covid-19-guidance-for-governors
Key Takeaway:
● The Johns Hopkins Center for Health Security offers a framework for considering risks
regarding the likelihood of disease transmission. As new cases of COVID-19 begin to
decline, there will need to be decisions at the state level about how to transition out of
strict physical distancing measures and into a phased reopening.
Title: A National Plan to Enable Comprehensive COVID-19 Case Finding and Contact
Tracing in the US
Publisher: The Johns Hopkins Center for Health Security
Publication: April 10, 2020
URL: https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200410national-plan-to-contact-tracing.pdf
Key Takeaway:
● The Johns Hopkins Center for Health Security and the Association of State and
Territorial Health Officials (ASTHO) propose a plan to dramatically scale up the public
health workforce in order to carry out aggressive case finding and epidemic containment
in the US over the course of the next year.
● This is similar to the approach currently being rolled out in Massachusetts and to the
NACCHO position statement.
Title: Policy and Public Health Recommendations for Easing COVID-19 Distancing
Restriction
Publisher: Infectious Disease Society of America
Publication: April 16, 2020
URL: https://www.idsociety.org/contentassets/9ba35522e0964d51a47ae3b22e59fb47/idsarecommendations-for-reducing-covid-19-distancing_16apr2020_final-.pdf
Key Takeaway:
● IDSA/HIMVA position outlining steps to ensure that “re-opening” areas at risk for
resurgent COVID-19 transmission is done as safely as possible.
● Continued physical distancing behaviors should be maintained until transmission is
measurably slowed to a manageable “baseline” level (R0 <1) such that cases are reduced
to a level that allows resumption of comprehensive and rapid case identification and the
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ability to conduct thorough contact tracing. This approach has proven effective in
controlling other respiratory infections like tuberculosis and SARS.
● The ability to re-open safely will depend on the ability to scale up aspects of the medical
and public health response spanning testing, treatment, prevention, and preparedness.

Title: Roadmap to Pandemic Resilience
Publisher: Harvard University Center for Ethics
Publication: April 20, 2020
URL: https://ethics.harvard.edu/files/center-forethics/files/roadmaptopandemicresilience_updated_4.20.20.pdf
Key Takeaway:
● This paper is designed to educate the American public about what is emerging as a
consensus national strategy from experts and thought leaders.
● This policy roadmap summarizes the above public health approaches, and integrates them
with a society-wide approach that can help rebuild trust in the safety of individuals and
the population, while supporting a renewal of mobility and mobilization of the economy.

ETHICS
Title: COVID-19 Ethics Resource Center
Publisher: American Medical Association Journal of Ethics
Publication: Continuously updated
URL: https://journalofethics.ama-assn.org/covid-19-ethics-resource-center
Key Takeaway:
● A collection of AMA resources and writings meant to promote ethical reflection around
challenges including rationing of limited health care resources, restriction of individual
movement and liberties, and the professional duty to treat in the face of personal danger.

RESOURCES
Title: CDC COVID-19 Surge Calculator
Publisher: US Centers for Disease Control and Prevention
Publication: April 21, 2020
URL: https://www.cdc.gov/coronavirus/2019-ncov/hcp/COVIDsurge.html
Key Takeaway:
● A spreadsheet-based tool that hospital administrators and public health officials can use
to estimate the surge in demand for hospital-based services during COVID-19 pandemic.
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● Users enter the population in the hospital catchment area number of cases to date, the
available hospital resources (non-ICU beds, ICU beds, and mechanical ventilators), and
up to three community mitigation strategies.

Title: COVID-19 Hospital Resource Package
Publisher: US DHHS ASPR TRACIE
Publication: April 24, 2020 (continuously updated)
URL: https://files.asprtracie.hhs.gov/documents/covid-19-hospital-resource-packagedocument.pdf
Key Takeaway:
● Resources for hospital administrators compiled by DHHS ASPR Technical Resources,
Assistance Center, and Information Exchange (TRACIE). Sections include Hospital
Surge, Crisis Standards of Care, Staffing Surge and Resilience, Workforce Protection,
HHS and CMS Regulatory Relief, Equipment Supply Surge, and Telemedicine. Though
these resources may be individually listed in prior Intelligence Reports, this brings those
together.
Title: N95 MASK RE-USE STRATEGIES
Publisher: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
Publication: April 17, 2020
URL: https://www.sages.org/n-95-re-use-instructions/
Key Takeaway:
● The CDC and NIOSH do not formally recommend decontamination and re-use of N95
masks, but acknowledge that in times of scarcity such strategies can be used based on
individual clinical judgment and the institutional resources available.
● Because coronaviruses lose their viability significantly after 72 hours, organizations have
promoted a rotation and re-use strategy. Assuming no soiling and minimal to no viral
contamination to the mask, this guidance suggests a strategy for reusing N95 masks.

GWU RESEARCH OPPORTUNITIES
Special Intramural Funding Opportunity: COVID-19 Research Fund
Publisher: George Washington University
URL: https://research.gwu.edu/covid-19-research-fund
Key Takeaway:
• The goal of the COVID-19 Research Fund is to support as many high-impact projects as
possible with the allocated funding. In anticipation of a high volume of proposals, we ask
that applicants only request funding that cannot be secured elsewhere and that is critical
to achieve the project’s objectives.
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EMERGING CONVERSATIONS*
● WHO cautions against interpreting results of serologic studies to indicate immunity (CNN).
● Serologic testing in Santa Clara County, CA suggests substantially more widespread
asymptomatic infection than previously indicated (Medrxiv).
● Reports of blood clotting complications in some young patients (Washington Post).
● Accuracy of rapid molecular test for COVID-19 questioned (NPR).
● Europe and New York strain of SARS-CoV-2 may be deadlier than others (Medrxiv).
● Hydroxychloroquine did not improve outcomes and was associated with higher mortality in
VA study (Medrxiv).
● Poison control centers in several states report an increase in calls related to accidental
ingestions of household cleaners (Business Insider).
The information in this section includes preprints, news reports, and other sources that have not
yet been certified by peer review or other independent validation. This information should not be
relied on to guide clinical practice or other critical decision-making without further confirmation.

10

